Opioid prescribing varies considerably across England and is especially marked in areas of high socio-economic deprivation, a study shows. 

This CPD module provides community pharmacists with an overview of some of the major developments in pharmacy practice during the past 12 months. 

The MHRA is asking healthcare professionals to give patients “stronger warnings” on the risks of opioids.

The General Pharmaceutical Council’s clampdown on rogue online pharmacies appears to be gathering pace.

WHO retracted the guidelines amid allegations that drug manufacturers had undue influence on their development.  

Social deprivation and lack of access to information are potential factors in prescription drug dependence.

Helping customers choose the right topical analgesic for their individual needs is key if they are to gain optimum benefit.

The prescription opioid time bomb has focused clinical attention on chronic pain and inspired a raft of management initiatives across the UK.

Opioid over-prescribing, medical cannabis and digital health developments were some of the topics covered

Pharmacy bodies have collaborated on a learning resource on the events at Gosport, which saw at least 450 patients die

An initiative being pioneered by a world authority on pain management relies on pharmacists helping to reduce opioid risk

Non-opioid analgesics improved pain-related function over 12 months as much as opioids in back or osteoarthritic pain

A CQC report has found that pharmacists prescribed almost twice as many controlled drugs (CDs) in 2016 as in the previous year

Data suggests pharmacists in Scotland’s National Naloxone Programme are reducing opioid-related deaths